Literature DB >> 30033372

Telomere Loop Dynamics in Chromosome End Protection.

David Van Ly1, Ronnie Ren Jie Low2, Sonja Frölich2, Tara K Bartolec2, Georgia R Kafer2, Hilda A Pickett3, Katharina Gaus4, Anthony J Cesare5.   

Abstract

Telomeres regulate DNA damage response (DDR) and DNA repair activity at chromosome ends. How telomere macromolecular structure contributes to ATM regulation and its potential dissociation from control over non-homologous end joining (NHEJ)-dependent telomere fusion is of central importance to telomere-dependent cell aging and tumor suppression. Using super-resolution microscopy, we identify that ATM activation at mammalian telomeres with reduced TRF2 or at human telomeres during mitotic arrest occurs specifically with a structural change from telomere loops (t-loops) to linearized telomeres. Additionally, we find the TRFH domain of TRF2 regulates t-loop formation while suppressing ATM activity. Notably, we demonstrate that ATM activation and telomere linearity occur separately from telomere fusion via NHEJ and that linear DDR-positive telomeres can remain resistant to fusion, even during an extended G1 arrest, when NHEJ is most active. Collectively, these results suggest t-loops act as conformational switches that specifically regulate ATM activation independent of telomere mechanisms to inhibit NHEJ.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  ATM; Aurora B kinase; DNA damage response; TRF2; mitosis; non-homologous end joining; super-resolution microscopy; telomere loops; telomere protection; telomeres

Mesh:

Substances:

Year:  2018        PMID: 30033372     DOI: 10.1016/j.molcel.2018.06.025

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  41 in total

1.  CD4+ memory T cells infected with latent HIV-1 are susceptible to drugs targeting telomeres.

Authors:  Dorota Piekna-Przybylska; Sanjay B Maggirwar
Journal:  Cell Cycle       Date:  2018-09-20       Impact factor: 4.534

2.  Targeted and Persistent 8-Oxoguanine Base Damage at Telomeres Promotes Telomere Loss and Crisis.

Authors:  Elise Fouquerel; Ryan P Barnes; Shikhar Uttam; Simon C Watkins; Marcel P Bruchez; Patricia L Opresko
Journal:  Mol Cell       Date:  2019-05-14       Impact factor: 17.970

Review 3.  Alternative Lengthening of Telomeres: Building Bridges To Connect Chromosome Ends.

Authors:  Song My Hoang; Roderick J O'Sullivan
Journal:  Trends Cancer       Date:  2020-01-23

Review 4.  The Connection Between Cell Fate and Telomere.

Authors:  Ayse Basak Engin; Atilla Engin
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 5.  Therapeutic Targets in Telomerase and Telomere Biology of Cancers.

Authors:  Rajendra Prasad; Deeksha Pal; Wajid Mohammad
Journal:  Indian J Clin Biochem       Date:  2020-03-10

Review 6.  Genome rearrangements associated with aberrant telomere maintenance.

Authors:  Ragini Bhargava; Matthias Fischer; Roderick J O'Sullivan
Journal:  Curr Opin Genet Dev       Date:  2020-03-04       Impact factor: 5.578

7.  Mechanism of MRX inhibition by Rif2 at telomeres.

Authors:  Florian Roisné-Hamelin; Sabrina Pobiega; Kévin Jézéquel; Simona Miron; Jordane Dépagne; Xavier Veaute; Didier Busso; Marie-Hélène Le Du; Isabelle Callebaut; Jean-Baptiste Charbonnier; Philippe Cuniasse; Sophie Zinn-Justin; Stéphane Marcand
Journal:  Nat Commun       Date:  2021-05-12       Impact factor: 14.919

Review 8.  Twenty years of t-loops: A case study for the importance of collaboration in molecular biology.

Authors:  Ľubomír Tomáška; Anthony J Cesare; Taghreed M AlTurki; Jack D Griffith
Journal:  DNA Repair (Amst)       Date:  2020-06-26

Review 9.  The role of the DFF40/CAD endonuclease in genomic stability.

Authors:  Merve Kulbay; Nathan Bernier-Parker; Jacques Bernier
Journal:  Apoptosis       Date:  2021-01-02       Impact factor: 4.677

Review 10.  Telomeres in toxicology: Occupational health.

Authors:  Mohammad Shoeb; Helen C S Meier; James M Antonini
Journal:  Pharmacol Ther       Date:  2020-11-08       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.